Cytoplasmic transfer is a procedure in which the intracellular content of a healthy, high-quality egg is aspirated and injected into the patient’s egg prior to fertilization.
This technology improves egg quality and significantly increases IVF success rates. Scientific studies have shown that transferring healthy cytoplasm enhances egg cell function and boosts reproductive potential.
As one of modern medicine’s most innovative methods, cytoplasmic transfer offers couples a solution-oriented treatment option. It represents a breakthrough particularly for women of advanced maternal age or those with diminished ovarian reserve who wish to achieve pregnancy with their own eggs.
With age, egg quality naturally declines, negatively affecting fertility potential. However, cytoplasmic transfer restores this capacity, raising pregnancy rates considerably. It is also especially beneficial for patients with repeated IVF failures, as it supports mitochondrial function within the egg, thereby improving chances of a healthy pregnancy.
Another important advantage of cytoplasmic transfer is its potential to reduce the risk of passing on genetic disorders. Damaged mitochondria can be replaced with healthy cytoplasm, helping prevent the transmission of certain inherited diseases.
Cytoplasm contains essential organelles such as mitochondria, ribosomes, and the Golgi apparatus. Importantly, mitochondrial mRNA does not alter the genetic structure of the egg, as the egg’s genetic material remains safely stored and unchanged in the nucleus.
